Novartis' cancer treatment Kymriah gets Japan nod at cost of $305,800

Indonesia Berita Berita

Novartis' cancer treatment Kymriah gets Japan nod at cost of $305,800
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 Reuters
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 97%

A Japanese government panel approved Novartis' cancer treatment Kymriah at ...

FILE PHOTO: Logo of Swiss drugmaker Novartis is seen at its branch in Schweizerhalle near Basel, Switzerland, March 29, 2018. REUTERS/Arnd Wiegmann/File Photo

The Swiss drugmaker aims to use the one-time personalized therapy in Japan for children and young people with acute lymphoblastic leukemia and adult patients with diffuse large B-cell lymphoma .

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

Reuters /  🏆 2. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Justice Ruth Bader Ginsburg gets 'best fight' MTV Movie award nodJustice Ruth Bader Ginsburg gets 'best fight' MTV Movie award nodU.S. Supreme Court Justice Ruth Bader Ginsburg scored nominations on Tuesday for...
Baca lebih lajut »

Lawsuit accuses Gilead of propping up cost of lifesaving HIV treatments by blocking generic competitionLawsuit accuses Gilead of propping up cost of lifesaving HIV treatments by blocking generic competitionThe complaint names drugmakers Bristol-Myers Squibb and Johnson & Johnson subsidiary Janssen Pharmaceuticals as co-defendants.
Baca lebih lajut »

Stocks making the biggest moves premarket: Disney, Intel, Etsy, Fox Corp, Costco, Novartis & moreSome of the names on the move ahead of the open.
Baca lebih lajut »

Novartis buys Takeda's dry eye drug for $3.4 billionNovartis buys Takeda's dry eye drug for $3.4 billionSwiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharma...
Baca lebih lajut »

Takeda sells dry eye drug to Novartis to help cut debtTakeda sells dry eye drug to Novartis to help cut debtTakeda Pharmaceutical Co Ltd agreed to sell its dry eye drug to Swiss drugmaker ...
Baca lebih lajut »

Novartis vows to fight U.S. price-fixing claims against Sandoz unitNovartis vows to fight U.S. price-fixing claims against Sandoz unitNovartis on Monday said claims of price fixing against its Sandoz generics unit ...
Baca lebih lajut »

Brazil government, central bank nod to rapidly deteriorating GDP, fiscal positionBrazil government, central bank nod to rapidly deteriorating GDP, fiscal positionBrazil's government and central bank said the country's economic and f...
Baca lebih lajut »

Electronic implants studied for treatment of drug additionElectronic implants studied for treatment of drug additionSHANGHAI (AP) — Patient Number One is a thin man, with a scabby face and bouncy knees. His head, shaved in preparation for surgery, is wrapped in a clean, white cloth. Years of drug use cost...
Baca lebih lajut »

David Ortiz says he wouldn't visit White House because of Trump's treatment of immigrantsDavid Ortiz says he wouldn't visit White House because of Trump's treatment of immigrants'You don’t want to go and shake hands with a guy who is treating immigrants like (expletive),' Big Papi said.
Baca lebih lajut »



Render Time: 2025-03-12 22:22:50